• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Scientists discover how the body’s killer cells attack cancer

by
September 6, 2025
in Biology
Reading Time: 3 mins read
0
Killer cells
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease.

Scientists are on the verge of a cancer breakthrough after working out how the body’s immune system targets cells devastated by the disease.

A new study has discovered that our natural killer cells, from the immune system which protect against disease and infections, instinctively recognise and attack a protein that drives cancer growth.

The experts say that by hijacking this protein, known as XPO1, they may be able to activate more killer cells to destroy the disease.

Scientists from the University of Southampton, working with experts worldwide, led the study and now believe it could offer new and less invasive forms of treatments.

The findings have been published in the Science Advances journal.

Lead author Professor of Hepatology Salim Khakoo, from Southampton, said it was previously believed that killer cells attack cancer cells in a random manner.

He added: “Our findings actually show how our body’s immune system recognises and attacks these cancer cells.

“Killer cells are an emerging form of immunotherapy that shows huge promise.

“They don’t attack healthy tissue in the way chemotherapy and other immunotherapies do, so are safer and have less side-effects than traditional forms of cancer treatment.”

The XPO1 protein examined by the scientists is essential for normal cell function.

However, in many cancers, it becomes overactive and allows malignant cells to multiply unchecked.

The Southampton scientists found that a peptide – short chains of amino acids – derived from the XPO1 protein attracted the natural killer cells.

This, they say, triggers the body’s immune response against the cancerous cells.

Prof Khakoo added: “Patients with cancer who had both active killer cells and high levels of XPO1 had significantly better survival rates.

“This holds true for a range of cancers including those with higher rates of death such as liver cancer, which has an average survival rate of only 18 months.

“As well as liver cancer, killer cell treatment in the future could be used to treat head and neck cancers, endometrial, bladder or breast cancer.”

Previous studies have linked natural killer cells to the body’s protection against cancer.

Co-author Professor Ralf Schittenhelm, from Monash University in Australia, said the discovery could change the course of immunotherapy.

“We hope it could lead to personalised cancer treatment, especially in cases where traditional therapies have failed.

“The potential to develop targeted therapies that utilise the body’s own immune system is incredibly exciting.”

The scientific team at Southampton are now working on the development of the world’s first vaccine that uses natural killer cells to fight cancer.

Read more about the study in Science Advances at https://www.science.org/doi/10.1126/sciadv.ado6566.

ENDS
455 WORDS



Journal

Science Advances

DOI

10.1126/sciadv.ado6566

Method of Research

Randomized controlled/clinical trial

Subject of Research

People

Article Title

The nuclear export protein XPO1 provides a peptide ligand for natural killer cells

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Ancient Ear Bones Rewrite the Story of Freshwater Fish Evolution

October 2, 2025
Newly Discovered Tiny Prehistoric Fish Sheds Light on the Origins of Catfish and Carp

Newly Discovered Tiny Prehistoric Fish Sheds Light on the Origins of Catfish and Carp

October 2, 2025

Montana State Scientists Uncover New Insights Into Virus Replication and Infection

October 2, 2025

Exploring Amanita Mitochondrial Genomes and Phylogeny

October 2, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    91 shares
    Share 36 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    80 shares
    Share 32 Tweet 20
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How Does Cellular Activity in Early Life Impact Cancer and Aging?

NJIT Study Reveals Vision Therapy Restores Clarity from Concussion-Induced Double and Blurred Vision

Pseudokinases Drive Peptide Cyclization via Thioether Crosslinking

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.